https://en.sputniknews.africa/20231208/global-vaccine-alliance-approves-1-bln-fund-for-vaccine-production-in-africa-1064026365.html
Global Vaccine Alliance Approves $1 Billion Fund for Vaccine Production in Africa
Global Vaccine Alliance Approves $1 Billion Fund for Vaccine Production in Africa
Sputnik Africa
The African Union has set an ambitious goal for African countries to produce and deliver more than 60% of the continent's vaccine needs by 2040. Currently, the... 08.12.2023, Sputnik Africa
2023-12-08T17:55+0100
2023-12-08T17:55+0100
2023-12-09T08:58+0100
sub-saharan africa
healthcare
health
african union (au)
world health organization (who)
vaccine
malaria
cholera
funding
finance
https://cdn1.img.sputniknews.africa/img/07e7/04/16/1058775607_0:0:3069:1726_1920x0_80_0_0_5094f6fe515645596b863f60737c62d4.jpg
The Global Alliance for Vaccines (GAVI) announced the creation of a financial instrument that will provide up to $1 billion to support sustainable vaccine production in Africa.The funding is intended to contribute not only to healthy global vaccine markets, but also to outbreak and pandemic prevention, preparedness, response and sustainability, the organization said.The Alliance argued that Africa has suffered the most from COVID-19 vaccine inequities and has the most to gain from sustainable growth in the vaccine industry.The new financial mechanism is designed to provide two types of incentive payments to offset some of the initial high costs of production. The first type of payment, or "interim payment", is triggered when a manufacturer producing one of the vaccines included in GAVI's priority market group of vaccines succeeds in obtaining WHO prequalification.The second type, called an "accelerator payment," would be paid as a "supplement" per dose on top of the proposed market prices that manufacturers receive if they win GAVI-UNICEF tenders.GAVI is an international organization founded in 2000 to improve access to new and underused vaccines for children in the world's poorest countries, according to its website.
https://en.sputniknews.africa/20231113/this-african-country-vaccinated-almost-100k-animals-due-to-anthrax-1063510410.html
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2023
Maxim Grishenkin
https://cdn1.img.sputniknews.africa/img/07e7/0a/17/1063018107_0:0:1104:1103_100x100_80_0_0_03090c85a11f5d2e8a19cf1d989443c9.jpg
Maxim Grishenkin
https://cdn1.img.sputniknews.africa/img/07e7/0a/17/1063018107_0:0:1104:1103_100x100_80_0_0_03090c85a11f5d2e8a19cf1d989443c9.jpg
News
en_EN
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Maxim Grishenkin
https://cdn1.img.sputniknews.africa/img/07e7/0a/17/1063018107_0:0:1104:1103_100x100_80_0_0_03090c85a11f5d2e8a19cf1d989443c9.jpg
healthcare, health, african union (au), world health organization (who), vaccine, malaria, cholera, funding, finance
healthcare, health, african union (au), world health organization (who), vaccine, malaria, cholera, funding, finance
Global Vaccine Alliance Approves $1 Billion Fund for Vaccine Production in Africa
17:55 08.12.2023 (Updated: 08:58 09.12.2023) The African Union has set an ambitious goal for African countries to produce and deliver more than 60% of the continent's vaccine needs by 2040. Currently, the continent produces only one percent.
The Global Alliance for Vaccines (GAVI) announced the creation of a financial instrument that will provide up to $1 billion to support sustainable vaccine production in Africa.
The funding is intended to contribute not only to healthy global
vaccine markets, but also to outbreak and pandemic prevention, preparedness, response and sustainability, the organization said.
"A sustainable expansion of Africa’s vaccine manufacturing capacity would have a double payoff for the continent, contributing to the growth of a high-value biotechnology sector on the continent at the same time as supporting pandemic and outbreak prevention and response," the GAVI explained.
The Alliance argued that
Africa has suffered the most from COVID-19 vaccine inequities and has the most to gain from sustainable growth in the vaccine industry.
"Africa already accounts for around 20% of the world's population, yet the continent's vaccine industry provides only around 0.2% of global supply," the organization noted.
The new financial mechanism is designed to provide two types of incentive payments to offset some of the initial high costs of production.
The first type of payment, or "interim payment", is triggered when a manufacturer producing one of the vaccines included in GAVI's priority market group of vaccines succeeds in obtaining WHO prequalification.
Vaccines against diseases such as cholera, malaria, measles, yellow fever, and Ebola have been prioritized by GAVI.
The second type, called an "accelerator payment," would be paid as a "supplement"
per dose on top of the proposed market prices that manufacturers receive if they win GAVI-UNICEF tenders.
GAVI is an international organization founded in 2000 to improve access to new and underused vaccines for children in the world's poorest countries, according to its website.
